IDEAYA Biosciences, Inc.
IDYA
$25.00
$0.140.56%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 669.74M | 692.51M | 676.32M | 920.03M | 701.66M |
Total Receivables | -- | -- | 3.00K | 20.00K | 1.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 15.86M | 15.36M | 13.39M | 12.17M | 11.52M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 685.60M | 707.87M | 689.71M | 932.21M | 713.18M |
|
|||||
Total Current Assets | 685.60M | 707.87M | 689.71M | 932.21M | 713.18M |
Net Property, Plant & Equipment | 32.73M | 33.30M | 27.74M | 26.62M | 8.43M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 805.00K | 805.00K | 805.00K | 911.00K | 986.00K |
Total Assets | 1.04B | 1.10B | 1.12B | 1.24B | 973.66M |
|
|||||
Total Accounts Payable | 17.27M | 17.63M | 15.42M | 12.57M | 15.89M |
Total Accrued Expenses | 37.75M | 32.91M | 30.35M | 28.09M | 24.25M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 318.00K | 308.00K | 298.00K | -- | 606.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 55.34M | 50.85M | 46.07M | 40.66M | 40.74M |
|
|||||
Total Current Liabilities | 55.34M | 50.85M | 46.07M | 40.66M | 40.74M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 26.28M | 25.66M | 18.87M | 18.80M | 1.26M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 81.62M | 76.51M | 64.94M | 59.46M | 42.01M |
|
|||||
Common Stock & APIC | 1.73B | 1.72B | 1.68B | 1.67B | 1.37B |
Retained Earnings | -772.51M | -695.02M | -622.84M | -492.53M | -440.71M |
Treasury Stock & Other | 1.52M | 1.59M | 812.00K | 3.84M | -1.42M |
Total Common Equity | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M |
|